Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes

被引：0
作者：
Masahiko Sugimoto
Chiharu Handa
Kazufumi Hirano
Toshiyuki Sunaya
Mineo Kondo
机构：
[1] Mie University Graduate School of Medicine,Department of Ophthalmology
[2] Bayer Yakuhin,Medical Affairs & Pharmacovigilance
[3] Ltd.,Research & Development Japan
[4] Bayer Yakuhin,undefined
[5] Ltd.,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Diabetic macular edema; Intravitreal aflibercept; Anti-vascular endothelial growth factor treatment; Real-world clinical practice;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3489 / 3498
页数：9
相关论文
共 50 条
[1]   Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes [J].
Sugimoto, Masahiko ;
Handa, Chiharu ;
Hirano, Kazufumi ;
Sunaya, Toshiyuki ;
Kondo, Mineo .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (11) :3489-3498
[2]   Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes [J].
Shimura, Masahiko ;
Fukumatsu, Makoto ;
Tsujimura, Jun ;
Hirano, Kazufumi ;
Sunaya, Toshiyuki .
CLINICAL OPHTHALMOLOGY, 2022, 16 :579-592
[3]   Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study [J].
Donati, Simone ;
Yang, Chang-Hao ;
Xu, Xun ;
Mura, Marco ;
Giocanti-Auregan, Audrey ;
Hoerauf, Hans ;
Allmeier, Helmut ;
Machewitz, Tobias ;
Johnson, Kristian T. ;
Santoro, Elina .
OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) :161-178
[4]   Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study [J].
Simone Donati ;
Chang-Hao Yang ;
Xun Xu ;
Marco Mura ;
Audrey Giocanti-Aurégan ;
Hans Hoerauf ;
Helmut Allmeier ;
Tobias Machewitz ;
Kristian T. Johnson ;
Elina Santoro .
Ophthalmology and Therapy, 2024, 13 :161-178
[5]   Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study [J].
Giocanti-Auregan, Audrey ;
Donati, Simone ;
Hoerauf, Hans ;
Allmeier, Helmut ;
Rittenhouse, Kay D. ;
Machewitz, Tobias ;
Yang, Chang-Hao .
OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) :179-203
[6]   Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study [J].
Audrey Giocanti-Aurégan ;
Simone Donati ;
Hans Hoerauf ;
Helmut Allmeier ;
Kay D. Rittenhouse ;
Tobias Machewitz ;
Chang-Hao Yang .
Ophthalmology and Therapy, 2024, 13 :179-203
[7]   Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study [J].
Isik, Puren ;
Sizmaz, Selcuk ;
Esen, Ebru ;
Uysal, Anil ;
Demircan, Nihal .
INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (11) :4171-4180
[8]   Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study [J].
Puren Isik ;
Selcuk Sizmaz ;
Ebru Esen ;
Anıl Uysal ;
Nihal Demircan .
International Ophthalmology, 2023, 43 :4171-4180
[9]   Aflibercept in a real-world setting: the AURIGA study 24-month results of the German cohort of treatment-naive patients with macular edema following retinal vein occlusion receiving intravitreal aflibercept [J].
Wachtlin, Joachim ;
Kaymak, Hakan ;
Hoerauf, Hans ;
Allmeier, Helmut ;
Machewitz, Tobias ;
Scholz, Paula ;
Schuerks, Markus ;
Feltgen, Nicolas .
OPHTHALMOLOGIE, 2024, 121 (08) :650-657
[10]   Aflibercept in the clinical routine: the AURIGA study. The 24-month results of the German cohort of treatment-naïve patients with diabetic macular edema receiving intravitreal aflibercept [J].
Ulbig, Michael ;
Brinkmann, Christian Karl ;
Mirshahi, Alireza ;
Hoerauf, Hans ;
Allmeier, Helmut ;
Machewitz, Tobias ;
Scholz, Paula ;
Keramas, Georgios ;
Khoramnia, Ramin .
OPHTHALMOLOGIE, 2024, 121 (11) :894-903
12345